Key statistics
On Friday, Abivax SA (2X1:DUS) closed at 93.10, -23.56% below its 52-week high of 121.80, set on Dec 29, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 93.10 |
|---|---|
| High | 93.10 |
| Low | 93.10 |
| Bid | 98.00 |
| Offer | 98.90 |
| Previous close | 94.70 |
| Average volume | 23.60 |
|---|---|
| Shares outstanding | 79.07m |
| Free float | 72.76m |
| P/E (TTM) | -- |
| Market cap | 7.55bn EUR |
| EPS (TTM) | -3.09 EUR |
Data delayed at least 15 minutes, as of Feb 06 2026 07:11 GMT.
More ▼
Announcements
- Abivax to be Added to Nasdaq Biotechnology Index
- Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
- Abivax Presents First Half 2025 Financial Results
- Abivax Announces Closing of $747.5 Million Public Offering
- Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)
- Abivax announces trading resumption of its ordinary shares on Euronext Paris
- Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares
- Abivax announces temporary trading halt of its ordinary shares on Euronext Paris
- Abivax Presents First Quarter 2025 Financial Results
- Abivax publishes financial reports with the French and U.S. securities regulatory agencies
More ▼
